Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 14 de 14
Filtrer
Plus de filtres










Base de données
Gamme d'année
4.
Skin Appendage Disord ; 2(3-4): 102-108, 2017 Jan.
Article de Anglais | MEDLINE | ID: mdl-28232916

RÉSUMÉ

BACKGROUND: Nail psoriasis is a painful and disfiguring nail disease that often leads to invasive biopsies. Dermoscopy of the hyponychium can be useful in the diagnosis showing twisted coiled vessels. Structural features of nail psoriasis have been described with optical coherence tomography (OCT). OBJECTIVES: To investigate vascular features of nail psoriasis using dynamic OCT. METHODS: This was an observational, prospective, controlled study in which psoriasis patients with psoriatic nail changes and healthy control patients underwent OCT imaging of the distal nail plate and proximal nail fold. Vertical and horizontal OCT images were analyzed to describe structural and vascular features and to quantify blood flow at depth. RESULTS: Sixteen psoriatic nails and 16 control nails were included. Psoriatic nails had significantly increased blood flow in the proximal nail fold at depths of 0.72 mm (p = 0.035) and 0.76 mm (p = 0.027). Nail thickness was significantly greater in psoriatic nails compared to control nails (p = 0.0016). Compared to control nails, psoriatic nails had dilated, disorganized blood vessels superficially in the proximal nail fold. LIMITATIONS: The main limitation of our study is the relatively small sample size. CONCLUSIONS: OCT can identify structural and vascular features specific to nail psoriasis.

5.
J Drugs Dermatol ; 15(6): 713-4, 2016 Jun 01.
Article de Anglais | MEDLINE | ID: mdl-27272077

RÉSUMÉ

Cherry hemangiomas are common vascular proliferative lesions that can be concerning from a cosmetic perspective. Laser therapy is often used to eradicate cherry hemangiomas, but some lesions require multiple treatments or do not resolve at all. The suboptimal response to laser treatment may be due to limitations in penetration depth by vascular lasers such as the pulsed dye laser. Optical coherence tomography is a low-energy, light-based imaging device that can evaluate the depth and extent of vascular lesions such as cherry hemangiomas by allowing visualization of tissue structure and blood vessel architecture, which cannot be appreciated by clinical or dermatoscopic examination alone. We present optical coherence tomography images of a cherry hemangioma to demonstrate the precision and resolution of this imaging modality. Optical coherence tomography provides valuable information that has the potential to predict response to laser therapy without unnecessary attempts. Future prospective studies will determine its value for this purpose.

J Drugs Dermatol. 2016;15(6):713-714.


Sujet(s)
Hémangiome/imagerie diagnostique , Tumeurs cutanées/imagerie diagnostique , Tomographie par cohérence optique/statistiques et données numériques , Adulte , Femelle , Hémangiome/radiothérapie , Humains , Lasers à colorant/statistiques et données numériques , Tumeurs cutanées/radiothérapie
7.
JAMA Dermatol ; 151(7): 715-21, 2015 Jul.
Article de Anglais | MEDLINE | ID: mdl-25714607

RÉSUMÉ

IMPORTANCE: The 2-step dermoscopy algorithm aims to guide the decision-making process to biopsy or not biopsy a skin lesion by providing the most probable diagnosis via a systematic approach. OBJECTIVE: To evaluate the diagnostic accuracy and potential limitations of the first step (to differentiate melanocytic from nonmelanocytic lesions) of the 2-step dermoscopy algorithm. DESIGN, SETTING, AND PARTICIPANTS: Retrospective study in a clinical practice of one dermatologist of biopsy data of all skin lesions from one clinic during a 10-year period. The prebiopsy and histopathology diagnoses were classified as melanocytic or nonmelanocytic. MAIN OUTCOMES AND MEASURES: The diagnostic accuracy, sensitivity, specificity, positive predictive value, and negative predictive value for the first step were estimated using the histopathological lesion classifications as the standard. RESULTS: The sensitivity of the first step for correctly identifying melanocytic lesions was 85%, and the specificity was 94%. Approximately 7% of all lesions (667 of 9168) had discordant classifications, with 415 (4.5%) being false-positive lesions (clinically classified as melanocytic and histopathologically classified as nonmelanocytic) and 252 (2.7%) being false negatives (clinically classified as nonmelanocytic and histopathologically classified as melanocytic). Common classification errors included intradermal nevus misclassified as basal cell carcinoma and nonmelanocytic lesions (eg, seborrheic keratosis, lichen planus-like keratosis, basal cell carcinomas) misclassified as melanocytic because they mimic melanoma. Clinically, 8 of 381 melanomas were misclassified as nonmelanocytic (primarily as pigmented basal cell carcinomas and squamous cell carcinomas). CONCLUSIONS AND RELEVANCE: The 2-step dermoscopy algorithm, including its first step, has high sensitivity, specificity, and accuracy and can be relied on to provide an accurate and specific prebiopsy diagnosis and to help guide management decisions. Some lesions had a higher chance of being misclassified, with the most common being intradermal nevi. This algorithm helps toward maximizing the detection of skin cancer to ensure that malignant lesions are not missed and aims at making more precise clinical diagnoses.


Sujet(s)
Algorithmes , Carcinome basocellulaire/anatomopathologie , Carcinome épidermoïde/anatomopathologie , Dermoscopie/méthodes , Mélanome/anatomopathologie , Tumeurs cutanées/anatomopathologie , Biopsie , Techniques d'aide à la décision , Faux négatifs , Faux positifs , Humains , Pigmentation , Valeur prédictive des tests , Études rétrospectives , Peau/anatomopathologie
8.
J Neurosci ; 34(29): 9779-88, 2014 Jul 16.
Article de Anglais | MEDLINE | ID: mdl-25031415

RÉSUMÉ

Opioid analgesics are commonly used in chronic pain management despite a potential risk of rewarding. However, it remains unclear whether opioid analgesia would enhance the opioid rewarding effect thereby contributing to opioid rewarding. Utilizing a rat paradigm of conditioned place preference (CPP) combined with ankle monoarthritis as a condition of persistent nociception, we showed that analgesia induced by either morphine or the nonsteroid anti-inflammatory drug ibuprofen increased CPP scores in arthritic rats, suggesting that analgesia itself had a rewarding effect. However, arthritic rats exhibited a significantly higher CPP score in response to morphine than ibuprofen. Thus, the rewarding effect of morphine was enhanced in the presence of persistent nociception, producing a phenomenon of analgesia-enhanced opioid reward. At the cellular level, administration of morphine activated a cascade of leptin expression, glial activation, and dopamine receptor upregulation in the nucleus accumbens (NAc), while administration of ibuprofen decreased glial activation with no effect on leptin expression in the NAc. Furthermore, the morphine rewarding effect was blocked in leptin deficient ob/ob mice or by neutralizing leptin or interleukin-1ß in the NAc without diminishing morphine analgesia. The data indicate that systemic opioid can activate a leptin-mediated central mechanism in the NAc that led to the enhanced opioid rewarding effect. These findings provide evidence for an interaction between opioid analgesia and opioid rewarding, which may have implications in clinical opioid dose escalation in chronic pain management.


Sujet(s)
Analgésiques morphiniques/administration et posologie , Leptine/physiologie , Morphine/administration et posologie , Douleur/traitement médicamenteux , Récompense , Animaux , Animaux nouveau-nés , Arthrite expérimentale/complications , Astrocytes/effets des médicaments et des substances chimiques , Cortex cérébral/cytologie , Conditionnement opérant/effets des médicaments et des substances chimiques , Conditionnement opérant/physiologie , Modèles animaux de maladie humaine , Régulation de l'expression des gènes/effets des médicaments et des substances chimiques , Régulation de l'expression des gènes/génétique , Leptine/génétique , Leptine/pharmacologie , Mâle , Souris , Souris de lignée C57BL , Souches mutantes de souris , Mutation/génétique , Douleur/étiologie , Mesure de la douleur/effets des médicaments et des substances chimiques , Seuil nociceptif/effets des médicaments et des substances chimiques , Rats , Rat Sprague-Dawley
9.
Anat Rec (Hoboken) ; 296(6): 953-64, 2013 Jun.
Article de Anglais | MEDLINE | ID: mdl-23596149

RÉSUMÉ

Liver sinusoids are lined by a fenestrated endothelium that lacks a basement membrane. Formation of perisinusoidal basement membranes beneath the endothelium is an integral feature of capillarization of sinusoids that is a significant pathology found in advanced fibrosis. Liver fibrosis is prevalent in elderly cadavers; however, basement membrane formation in these liver samples has yet to be studied. Collagen type IV and laminin are major basement membrane proteins and their codistribution around sinusoids provides an immunohistochemical marker of basement membrane formation. Here, we examined the intralobular sites of perisinusoidal basement membrane formation in elderly cadaveric livers having various stages of fibrosis. Collagen IV and laminin codistributed in basement membranes of portal and septal ductular and vascular structures, providing a positive control. In the parenchyma, collagen IV immunostaining of sinusoids was panlobular in all stages of fibrosis, and the stain was continuous along the sinusoids. In contrast, laminin was not detected in livers, showing minimal fibrotic change. It was rarely seen in perisinusoidal/pericellular fibrosis, but frequently in septa formation, bridging fibrosis, and cirrhosis. The laminin stain was patchy, occurring principally in sinusoids of periportal and periseptal areas, less commonly in mid-lobular and rarely in centrilobular areas. Consecutive sections revealed that laminin codistributed with collagen IV in these sinusoidal locations, thus marking the sites of perisinusoidal basement membrane formation in aged fibrotic livers. This development is presumably related to aging of the liver and exacerbated by liver injury caused by advanced liver fibrosis, possibly resulting in sinusoidal capillarization.


Sujet(s)
Collagène de type IV/métabolisme , Laminine/métabolisme , Cirrhose du foie/métabolisme , Cirrhose du foie/anatomopathologie , Foie/anatomopathologie , Sujet âgé , Sujet âgé de 80 ans ou plus , Membrane basale/croissance et développement , Membrane basale/métabolisme , Marqueurs biologiques/métabolisme , Fibrose , Humains , Foie/vascularisation
10.
J Am Acad Dermatol ; 68(5): 825-33, 2013 May.
Article de Anglais | MEDLINE | ID: mdl-23267722

RÉSUMÉ

Desmoplastic melanoma (DM) is a variant of spindle cell melanoma typically found on chronically sun-damaged skin of older individuals. Early diagnosis can be challenging because it is often amelanotic and has a predominantly dermal component. DM can be difficult to diagnose not only clinically but also histologically, and can be mistaken for a variety of benign and malignant nonmelanocytic spindle cell tumors when viewed on prepared histopathology slides. Pathologists have observed that DMs can manifest significant variation with respect to the extent of intratumoral cellularity, fibrosis, and/or perineural invasion. Furthermore, some tumors present with a pure desmoplastic invasive component (>90%) while other tumors display mixed features of DM and nondesmoplastic melanoma. This has led to the separation of DM into 2 histologic subtypes, pure and mixed. With a focus on the distinction between pure and mixed DM, this review will detail what is currently known about the diagnostic features of DM, discuss risk and prognostic factors, and examine the current literature on disease progression and management.


Sujet(s)
Mélanome/anatomopathologie , Mélanome/thérapie , Tumeurs cutanées/anatomopathologie , Tumeurs cutanées/thérapie , Diagnostic différentiel , Diagnostic précoce , Humains , Mélanome/épidémiologie , Naevus à cellules fusiformes/épidémiologie , Naevus à cellules fusiformes/anatomopathologie , Naevus à cellules fusiformes/thérapie , Facteurs de risque , Tumeurs cutanées/épidémiologie
11.
Photodermatol Photoimmunol Photomed ; 28(5): 228-34, 2012 Oct.
Article de Anglais | MEDLINE | ID: mdl-22971186

RÉSUMÉ

Endogenous production and ultraviolet-generated free radicals in the skin can lead to photoaging and even skin cancer. Topical antioxidants have been found to provide benefits against ultraviolet damage and these ingredients have been incorporated into various cosmetic products and claimed to have substantial effects. Currently, there is a lack in a standardized rating system to measure the concentration and activity levels of antioxidants in these products. As a result, it is difficult for consumers and clinicians to evaluate and select commercial products based on readily accessible evidence. In this review, we will describe four assays which have been used to measure antioxidants in various products, and the strengths and weaknesses of each test will be detailed. We will highlight key considerations for clinicians when interpreting the results of antioxidant tests when evaluating commercial products containing antioxidants.


Sujet(s)
Antioxydants/analyse , Cosmétiques/analyse , Peau , Animaux , Antioxydants/pharmacologie , Cosmétiques/pharmacologie , Humains , Rayons ultraviolets
13.
J Clin Anesth ; 17(3): 198-201, 2005 May.
Article de Anglais | MEDLINE | ID: mdl-15896587

RÉSUMÉ

We report a case of general anesthesia for transurethral resection of the bladder in a 74-year-old male patient with uncorrected tetralogy of Fallot. This case illustrates the pertinent pathophysiology of the complex cardiac lesion related to tetralogy of Fallot as well as the feasibility and issues with regard to the anesthetic management.


Sujet(s)
Anesthésie , Cystectomie/méthodes , Tétralogie de Fallot/complications , Tumeurs de la vessie urinaire/chirurgie , Sujet âgé , Études de faisabilité , Humains , Mâle , Tétralogie de Fallot/physiopathologie , Tumeurs de la vessie urinaire/complications
14.
Pain ; 87(1): 7-17, 2000 Jul.
Article de Anglais | MEDLINE | ID: mdl-10863041

RÉSUMÉ

The effectiveness of systemic lidocaine in relieving acute and chronic pain has been recognized for over 35 years. In particular, systemic lidocaine has been utilized both as a diagnostic and therapeutic tool for intractable neuropathic pain during the last decade. The introduction of oral lidocaine congeners such as mexiletine has significantly extended the usage of lidocaine therapy in chronic pain settings. However, a number of clinical issues remain to be addressed including (1) an effective, meaningful dose range for the clinical lidocaine test, (2) the predictive value of the lidocaine test for an oral trial of lidocaine congeners, (3) identification of pain symptoms and signs relieved by systemic lidocaine, (4) comparisons of therapeutic effects between systemic lidocaine and its oral congeners, and (5) long-term outcomes of systemic lidocaine and its oral congeners. Mechanisms of neuropathic pain relief from lidocaine therapy are yet to be understood. Both central and peripheral mechanisms have been postulated. Systemic lidocaine is thought to have its suppressive effects on spontaneous ectopic discharges of the injured nerve without blocking normal nerve conduction. However, there remain inconsistencies in the scientific basis underlying the clinical application of lidocaine therapy. Recent demonstration of changes in tetrodotoxin (TTX)-sensitive and TTX-resistant sodium channels following nerve injury and their link to certain neuropathic pain symptoms may lead to the development of subtype-specific sodium channel blockers. The thoughtful use of lidocaine therapy and the potential application of subtype-specific sodium channel blockers could provide better management of distinctive neuropathic pain symptoms.


Sujet(s)
Analgésiques/usage thérapeutique , Lidocaïne/usage thérapeutique , Névralgie/traitement médicamenteux , Administration par voie orale , Analgésiques/administration et posologie , Animaux , Humains , Lidocaïne/administration et posologie , Méxilétine/usage thérapeutique , Névralgie/métabolisme , Bloqueurs de canaux sodiques
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...